Skip to main content
Top
Published in: Strahlentherapie und Onkologie 4/2017

01-04-2017 | Original Article

Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction

An alternative treatment option for locally advanced breast cancer

Authors: Montserrat Pazos, M.D., Dr. med. Stefanie Corradini, M.D., Darius Dian, M.D. D.Sc., Vera von Bodungen, M.D., Nina Ditsch, M.D., Rachel Wuerstlein, M.D., Stephan Schönecker, M.D., Nadia Harbeck, M.D., Heike Scheithauer, M.D., Claus Belka, M.D.

Published in: Strahlentherapie und Onkologie | Issue 4/2017

Login to get access

Abstract

Background

The optimal sequence of mastectomy with immediate breast reconstruction (IBR) and radiotherapy (RT) for the treatment of locally advanced breast cancer (LABC) is still under debate. Increased rates of postoperative complications are described following postmastectomy RT. Neoadjuvant RT aims to improve the aesthetic results and simplify the reconstructive pathway.

Patients

A total of 22 patients diagnosed with LABC and treated with neoadjuvant RT followed by mastectomy and IBR between 04/2012 and 03/2015 were retrospectively analyzed. RT consisted of external beam RT to the breast and the regional lymphatics, if indicated. Both implant-based and autologous tissue-transfer reconstruction techniques were used.

Results

At the time of RT, 10 patients had no prior surgery and 12 patients had previously undergone breast-conserving surgery (BCS) with positive resection margins without the possibility to perform a second BCS. Additional neoadjuvant chemotherapy was administered in 18 patients prior to RT. A complete pathological response was achieved in 55.0% of patients. The 2‑year overall survival rate was 89.3%, the 2‑year disease-free-survival 79.8% and the local-recurrence-free survival was 95.2%. The cosmetic result was excellent or good in 66% of the patients treated with upfront mastectomy and 37% of the patients who had previously undergone BCS. Among patients who received implant-based IBR, 4 patients developed serious wound-healing problems with implant loss. The most satisfactory results were achieved with autologous tissue reconstruction.

Conclusion

A sequential neoadjuvant chemo-/radiotherapy to allow IBR following mastectomy in selected cases of LABC seems feasible and can be safely attempted. Careful patient selection, close monitoring, and continuous patient support is mandatory to ensure compliance in this treatment strategy.
Literature
2.
go back to reference Bauerfeind I (2015) Empfehlung zur Diagnostik, Therapie und Nachsorge Mammakarzinome. Manual. Tumorzentrum, München Bauerfeind I (2015) Empfehlung zur Diagnostik, Therapie und Nachsorge Mammakarzinome. Manual. Tumorzentrum, München
5.
go back to reference Bear HD, Anderson S, Smith RE et al (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B‑27. J Clin Oncol 24:2019–2027. doi:10.1200/JCO.2005.04.1665 CrossRefPubMed Bear HD, Anderson S, Smith RE et al (2006) Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B‑27. J Clin Oncol 24:2019–2027. doi:10.​1200/​JCO.​2005.​04.​1665 CrossRefPubMed
6.
7.
go back to reference Budach W, Matuschek C, Bölke E et al (2015) DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 191:623–633. doi:10.1007/s00066-015-0843-1 CrossRefPubMedPubMedCentral Budach W, Matuschek C, Bölke E et al (2015) DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 191:623–633. doi:10.​1007/​s00066-015-0843-1 CrossRefPubMedPubMedCentral
8.
10.
go back to reference Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949–955. doi:10.1056/NEJM199710023371401 CrossRefPubMed Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949–955. doi:10.​1056/​NEJM199710023371​401 CrossRefPubMed
12.
go back to reference Sbitany H, Wang F, Peled AW et al (2014) Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg 134:396–404. doi:10.1097/PRS.0000000000000466 CrossRefPubMed Sbitany H, Wang F, Peled AW et al (2014) Immediate implant-based breast reconstruction following total skin-sparing mastectomy: defining the risk of preoperative and postoperative radiation therapy for surgical outcomes. Plast Reconstr Surg 134:396–404. doi:10.​1097/​PRS.​0000000000000466​ CrossRefPubMed
13.
go back to reference Mioton LM, Gaido J, Small W et al (2013) Differences in breast aesthetic outcomes due to radiation: a validated, quantitative analysis of expander-implant reconstruction. Can J Plast Surg 21:73–77CrossRefPubMedPubMedCentral Mioton LM, Gaido J, Small W et al (2013) Differences in breast aesthetic outcomes due to radiation: a validated, quantitative analysis of expander-implant reconstruction. Can J Plast Surg 21:73–77CrossRefPubMedPubMedCentral
14.
go back to reference Classen J, Nitzsche S, Wallwiener D et al (2010) Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients. Strahlenther Onkol 186:630–636. doi:10.1007/s00066-010-2158-6 CrossRefPubMed Classen J, Nitzsche S, Wallwiener D et al (2010) Fibrotic changes after postmastectomy radiotherapy and reconstructive surgery in breast cancer. A retrospective analysis in 109 patients. Strahlenther Onkol 186:630–636. doi:10.​1007/​s00066-010-2158-6 CrossRefPubMed
15.
go back to reference Hughes K, Brown C, Perez V et al (2012) The effect of radiotherapy on implant-based breast reconstruction in the setting of skin-sparing mastectomy: clinical series and review of complications. Anticancer Res 32:553–557PubMed Hughes K, Brown C, Perez V et al (2012) The effect of radiotherapy on implant-based breast reconstruction in the setting of skin-sparing mastectomy: clinical series and review of complications. Anticancer Res 32:553–557PubMed
18.
go back to reference Ribuffo D, Atzeni M, Guerra M et al (2013) Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthetic Plast Surg 37:1146–1152. doi:10.1007/s00266-013-0221-2 Ribuffo D, Atzeni M, Guerra M et al (2013) Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy. Aesthetic Plast Surg 37:1146–1152. doi:10.​1007/​s00266-013-0221-2
19.
go back to reference Krueger EA, Wilkins EG, Strawderman M et al (2001) Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 49:713–721CrossRefPubMed Krueger EA, Wilkins EG, Strawderman M et al (2001) Complications and patient satisfaction following expander/implant breast reconstruction with and without radiotherapy. Int J Radiat Oncol Biol Phys 49:713–721CrossRefPubMed
20.
go back to reference Giacalone PL, Rathat G, Daures JP et al (2010) New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study. Breast Cancer Res Treat 122:439–451. doi:10.1007/s10549-010-0951-7 CrossRefPubMed Giacalone PL, Rathat G, Daures JP et al (2010) New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study. Breast Cancer Res Treat 122:439–451. doi:10.​1007/​s10549-010-0951-7 CrossRefPubMed
21.
go back to reference Zinzindohoué C, Bertrand P, Michel A et al (2016) A prospective study on skin-sparing mastectomy for immediate breast reconstruction with latissimus dorsi flap after neoadjuvant chemotherapy and radiotherapy in invasive breast carcinoma. Ann Surg Oncol. doi:10.1245/s10434-016-5146-y Zinzindohoué C, Bertrand P, Michel A et al (2016) A prospective study on skin-sparing mastectomy for immediate breast reconstruction with latissimus dorsi flap after neoadjuvant chemotherapy and radiotherapy in invasive breast carcinoma. Ann Surg Oncol. doi:10.​1245/​s10434-016-5146-y
22.
go back to reference Paillocher N, Florczak AS, Richard M et al (2016) Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma. Eur J Surg Oncol. doi:10.1016/j.ejso.2016.03.024 Paillocher N, Florczak AS, Richard M et al (2016) Evaluation of mastectomy with immediate autologous latissimus dorsi breast reconstruction following neoadjuvant chemotherapy and radiation therapy: A single institution study of 111 cases of invasive breast carcinoma. Eur J Surg Oncol. doi:10.​1016/​j.​ejso.​2016.​03.​024
24.
go back to reference Chevallier B, Roche H, Olivier JP et al (1993) Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 16:223–228CrossRefPubMed Chevallier B, Roche H, Olivier JP et al (1993) Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol 16:223–228CrossRefPubMed
26.
go back to reference Budach W, Bölke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials – an update. Radiat Oncol 10:1–7. doi:10.1186/s13014-015-0568-4 CrossRef Budach W, Bölke E, Kammers K et al (2015) Adjuvant radiation therapy of regional lymph nodes in breast cancer – a meta-analysis of randomized trials – an update. Radiat Oncol 10:1–7. doi:10.​1186/​s13014-015-0568-4 CrossRef
27.
go back to reference Wu S‑G, Sun J‑Y, Zhou J et al (2014) Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy. Radiat Oncol 9:1–9. doi:10.1186/s13014-014-0284-5 CrossRef Wu S‑G, Sun J‑Y, Zhou J et al (2014) Number of negative lymph nodes can predict survival of breast cancer patients with four or more positive lymph nodes after postmastectomy radiotherapy. Radiat Oncol 9:1–9. doi:10.​1186/​s13014-014-0284-5 CrossRef
28.
29.
go back to reference Buzdar AU, Ibrahim NK, Francis D et al (2005) Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2‑positive operable breast cancer. J Clin Oncol 23:3676–3685. doi:10.1200/JCO.2005.07.032 CrossRefPubMed Buzdar AU, Ibrahim NK, Francis D et al (2005) Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2‑positive operable breast cancer. J Clin Oncol 23:3676–3685. doi:10.​1200/​JCO.​2005.​07.​032 CrossRefPubMed
30.
go back to reference Matuschek C, Bölke E, Roth SL et al (2012) Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis. Strahlenther Onkol 188:777–781. doi:10.1007/s00066-012-0162-8 CrossRefPubMed Matuschek C, Bölke E, Roth SL et al (2012) Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission : results of a multivariate analysis. Strahlenther Onkol 188:777–781. doi:10.​1007/​s00066-012-0162-8 CrossRefPubMed
31.
go back to reference Roth SL, Audretsch W, Bojar H et al (2010) Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlenther Onkol 186:299–306. doi:10.1007/s00066-010-2143-0 CrossRefPubMed Roth SL, Audretsch W, Bojar H et al (2010) Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy. Strahlenther Onkol 186:299–306. doi:10.​1007/​s00066-010-2143-0 CrossRefPubMed
32.
go back to reference Budach W, Matuschek C, Bölke E et al (2015) Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 191:634. doi:10.1007/s00066-015-0863-x CrossRefPubMedPubMedCentral Budach W, Matuschek C, Bölke E et al (2015) Erratum to: DEGRO practical guidelines for radiotherapy of breast cancer V: Therapy for locally advanced and inflammatory breast cancer, as well as local therapy in cases with synchronous distant metastases. Strahlenther Onkol 191:634. doi:10.​1007/​s00066-015-0863-x CrossRefPubMedPubMedCentral
33.
34.
go back to reference Desai S, Hurley J, Takita C et al (2013) Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy. Breast J 19(4):427–430. doi:10.1111/tbj.12140 CrossRefPubMed Desai S, Hurley J, Takita C et al (2013) Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy. Breast J 19(4):427–430. doi:10.​1111/​tbj.​12140 CrossRefPubMed
36.
go back to reference Clarke-Pearson EM, Chadha M, Dayan E et al (2013) Comparison of irradiated versus nonirradiated DIEP flaps in patients undergoing immediate bilateral DIEP reconstruction with unilateral postmastectomy radiation therapy (PMRT). Ann Plast Surg 71:250–254. doi:10.1097/SAP.0b013e31828986ec CrossRefPubMed Clarke-Pearson EM, Chadha M, Dayan E et al (2013) Comparison of irradiated versus nonirradiated DIEP flaps in patients undergoing immediate bilateral DIEP reconstruction with unilateral postmastectomy radiation therapy (PMRT). Ann Plast Surg 71:250–254. doi:10.​1097/​SAP.​0b013e31828986ec​ CrossRefPubMed
40.
go back to reference Lerouge D, Touboul E, Lefranc J‑P et al (2004) Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Int J Radiat Oncol Biol Phys 59:1062–1073. doi:10.1016/j.ijrobp.2003.12.034 CrossRefPubMed Lerouge D, Touboul E, Lefranc J‑P et al (2004) Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients. Int J Radiat Oncol Biol Phys 59:1062–1073. doi:10.​1016/​j.​ijrobp.​2003.​12.​034 CrossRefPubMed
Metadata
Title
Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction
An alternative treatment option for locally advanced breast cancer
Authors
Montserrat Pazos, M.D.
Dr. med. Stefanie Corradini, M.D.
Darius Dian, M.D. D.Sc.
Vera von Bodungen, M.D.
Nina Ditsch, M.D.
Rachel Wuerstlein, M.D.
Stephan Schönecker, M.D.
Nadia Harbeck, M.D.
Heike Scheithauer, M.D.
Claus Belka, M.D.
Publication date
01-04-2017
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 4/2017
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1100-6

Other articles of this Issue 4/2017

Strahlentherapie und Onkologie 4/2017 Go to the issue